IPO Price Range: ₹407 - 428
Min Investment
₹14,124
IPO Size
₹698 Cr
IPO Status
Live
Quantity in 1 Lot
33
Max Bid allowed
14
Listing Exchange
NSE
Bid Opening Date | 13 Jan 2025 |
Bid Closing Date | 15 Jan 2025 |
Allotment Date | 16 Jan 2025 |
Issue Size | ₹698.06Cr |
Quantity in 1 lot | 33 |
The only integrated dental products company in India, well-positioned to capture industry tailwinds.
Second largest player in domestic laboratory business and largest export laboratory with increasing adoption of digital dentistry.
Vertically integrated diverse branded product portfolio.
Large Dental Network providing us with competitive advantage in the market.
Robust technologically advanced capabilities with stringent regulatory compliance ensuring high quality standards.
Experienced management team with significant industry experience.
The Company has reported consolidated loss after tax, negative earning per share for Fiscals 2023 and 2022, and written off Assets in last three Fiscals and its cannot assure that the company will not experience such events in the future.
Its Statutory Auditors have included an emphasis of matter in their auditors report on its auditedfinancial statements as at and for the Financial Year ended 2024 and 2023.
Its business success depends on expanding the company Dental Network, recommendations by its Dental Network and increasing the wallet share per dental clinic, dental company and dentist. Failures to achieve this in a cost-effective manner could have an adverse effect on its business, results of operations and financial condition.
The companys business is concentrated in certain jurisdictions, globally and domestically, and any loss of business in such regions could have an adverse effect on its business, results of operations and financial condition.
There are outstanding legal proceedings involving the Company, Subsidiaries, Promoters, and Directors which could have an adverse effect on its business, financial condition and results of operations.
The companys business depends heavily on its reputation and perception of the company brands. Any negative publicity or other harm to its brand or failures to maintain and enhance the company brand recognition and maintain such quality standards may materially and adversely affect its reputation, business, results of operations and financial condition.
All its major manufacturing facilities are situated in and around Mumbai and any disruptions in the region could have a material and adverse effect on its business, financial condition and results of operations.
Import and Exports are material to its business operation. Further, a failures to manage the company business in overseas markets or its inability to grow the company business in new geographic markets may affect its growth, which could have a material adverse effect on its business, operations, prospects or financial condition.
Its inability to effectively manage the company growth or to successfully implement its business plan and growth and expansion strategy could have an adverse effect on the company business, results of operations and financial condition.
There is an outstanding legal proceeding involving its Promoter, Chairperson and Whole-time Director.Any adverse decision in such proceeding could have an adverse effect on its business, financial condition and results of operations.
Investors | Holdings % |
Rajesh Vrajlal Khakhar | 18.34% |
Sameer Kamlesh Merchant | 17.59% |
Dharmesh Bhupendra Dattani | 0.26% |
Jigna Rajesh Khakhar | 8.79% |
Hasmukh Vrajlal Khakhar | 0.31% |
Organisation | Laxmi Dental Ltd |
Headquarters | Mumbai |
Industry | Healthcare |